UnknownNot Applicable

Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism

China700 participantsStarted 2022-12-23

Plain-language summary

The purpose of this study is to identify risk factors of cancer-associated venous thrombosis and develop a prediction model to assist clinicians in tailoring anticoagulant therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * with a histological diagnosis of cancer. Exclusion Criteria: * received long-term anticoagulant therapy; * without a clear primary site of malignancy; * had a follow-up of fewer than 6 months.

What they're measuring

cancer-associated venous thrombosis

Timeframe: 12 months since receiving anti-cancer therapy

Trial details

NCT IDNCT05729464

SponsorYongsheng Jiang

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-01

Contact for this trial

Yongsheng Jiang, doctor

027-83662356 ysjiang.china@163.com

View on ClinicalTrials.gov More Venous Thromboses trials